Answers are grounded in this paper and cite their sources.
Asparagine synthetase, purified from an asparaginase-resistant mouse leukemia (RADA1), catalyzes the formation of l-asparagine, AMP, PPi, and l-glutamate from l-aspartate, l-glutamine, and ATP. l-Glutamine may be replaced by NH4+ as the amide nitrogen donor. The postulated intermediate, β-l-aspartyl adenylate, was prepared by organic synthesis. The enzyme catalyzes the synthesis of ATP from PPi and β-l-aspartyl adenylate. Asparagine synthetase was found to exhibit glutaminase activity both in the presence and absence of the other substrates needed for asparagine synthesis. Both the glutaminase and glutamine-dependent (but not the NH4+-dependent) synthetase activities require chloride ions; Cl- can be replaced by Br- or I-, but with much less activity. The enzyme is inhibited by l-2-amino-4-oxo-5-chloropentanoic acid (which binds, probably covalently, to the enzyme), aminomalonic acid, N-methyl-dl-aspartic acid, and several other compounds. These compounds or similar ones may be useful in augmenting asparaginase therapy of tumors.
No takes yet. Share an insight, caveat, or question.
Horowitz et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: